aibio
Listings ·
Nuwellis sets one-for-nine reverse stock split effective October 26
The split takes effect at 5:00 p.m. Eastern Time on October 26, 2026, and NUWE shares trade split-adjusted from October 27.
NUWE Nuwellis, Inc.
Nuwellis (NUWE) news NUWE reverse split and offering news
Latest Nuwellis news
- Company Updates
Nuwellis investor presentation cites 20% first-half revenue growth
The August 2026 deck says first-half revenue rose 20% and that cash runway extends through 2Q27.
- Company Updates
Nuwellis reports 14% second-quarter revenue growth and 76% gross margin
Net sales were $2.0 million in the quarter, and the company says recent financings extend its cash runway through the second quarter of 2027.
- Financings
Nuwellis prices $3.4 million registered direct offering at $2.59 a share
Ladenburg Thalmann & Co. Inc. is the exclusive placement agent, and the deal includes warrants to buy up to 1,310,890 shares.
- Listings
Nuwellis to effect one-for-thirty-five reverse stock split on June 25
The split takes effect at 5:00 p.m. Eastern Time on June 25, 2026, and NUWE shares trade split-adjusted from June 26.
- Company Updates
Nuwellis appoints Mike McCormick as chief executive officer
John Erb steps back from the executive role and remains Chairman of the Board, and the new chief executive takes over on June 30, 2026.
- Debt Financing
BioRestorative sets up $1,000,000 revolving loan from Bowery Group
BioRestorative Therapies can borrow up to $1,000,000 from Bowery Group LLC at 12%, and the same agreement brought three director resignations and three new directors designated by the lender. Its cash use in 2025 was $10.8 million.
- Financings
Nuwellis closes $6.0 million public offering priced at $0.30 a share
Ladenburg Thalmann & Co. Inc. was sole book-running manager, and the deal included Series C warrants for up to 60,000,000 shares.
- Company Updates
Nuwellis reports 26% first-quarter revenue growth and 70.1% gross margin
Net sales were $2.4 million, and the company reported about $2.2 million of cash and no debt at March 31, 2026.
Nuwellis annual financials
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $8.3 million | $8.7 million |
| Research and development | $2.7 million | $3.2 million |
| Net income (loss) | -$17.5 million | -$11.2 million |
| Cash from operations | -$10.8 million | -$9.6 million |
| Cash and equivalents | $1.1 million | $5.1 million |
Questions about Nuwellis
Did Nuwellis do a reverse stock split?
Our latest story on this, dated Oct 22, 2026: "Nuwellis sets one-for-nine reverse stock split effective October 26". The story links the filing or release it is based on. Read the story.
Has Nuwellis raised money recently?
Our latest story on this, dated Jul 31, 2026: "Nuwellis prices $3.4 million registered direct offering at $2.59 a share". The story links the filing or release it is based on. Read the story.
What is the ticker symbol of Nuwellis?
Nuwellis, Inc. trades under the ticker NUWE on NASDAQ.
Where is Nuwellis listed?
Nuwellis, Inc. is listed on NASDAQ.
Which country or territory is Nuwellis listed under?
Our directory records Nuwellis, Inc. under United States.
Does aibio.space cover Nuwellis?
aibio.space lists Nuwellis, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.
What was Nuwellis's revenue last year?
$8.3 million for the fiscal year ended Dec 31, 2025, as reported to the SEC.
Is Nuwellis profitable?
Nuwellis, Inc. reported a net loss of $17.5 million for the fiscal year ended Dec 31, 2025, and used $10.8 million of cash in operations, per its annual report to the SEC.
How much does Nuwellis spend on research and development?
$2.7 million in the fiscal year ended Dec 31, 2025, per its annual report.
How much cash does Nuwellis have?
$3.9 million in cash at Jun 30, 2026, per its 10-Q.
What is the latest Nuwellis (NUWE) stock news?
Our latest story on Nuwellis, dated Oct 22, 2026: "Nuwellis sets one-for-nine reverse stock split effective October 26". The split takes effect at 5:00 p.m. Eastern Time on October 26, 2026, and NUWE shares trade split-adjusted from October 27. Source.
How long will Nuwellis's cash last?
From our story of Aug 26, 2026: The August 2026 deck says first-half revenue rose 20% and that cash runway extends through 2Q27. Source.
Which other companies' news mentions Nuwellis?
Nuwellis is named in 1 of our story about other companies, most recently: "BioRestorative sets up $1,000,000 revolving loan from Bowery Group" (Jun 10, 2026). Source.
How can I follow Nuwellis (NUWE) news?
Press Follow on this page to add Nuwellis to your Following list, or subscribe to the aibio.space newsletter. We have published 9 stories naming Nuwellis so far, in Company Updates, Debt Financing, Financings, Listings.
Investor discussion: Nuwellis
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
- Listings
Reported a reverse stock split. SEC Form 8-K (Items 3.03,5.03,9.01). Source
- Listings
Reported a shareholder vote on a reverse stock split or more authorized shares. SEC Form 8-K (Items 5.07). Source
- Listings
Asked shareholders to approve a reverse stock split. SEC Form DEF 14A. Source
- Listings
Asked shareholders to approve a reverse stock split. SEC Form PRE 14A. Source
- Listings
Reported a reverse stock split. SEC Form 8-K (Items 3.03,5.03,9.01). Source
- Listings
Reported a reverse stock split. SEC Form 8-K (Items 7.01,9.01). Source
- Financings
Set up an at-the-market program to sell shares over time. SEC Form 424B4. Source
- Financings
Filed a registration statement for a share offering. SEC Form S-1. Source
Stock chart
Listing details
- Company
- Nuwellis, Inc.
- Ticker
- NUWE
- Listing
- NASDAQ
- Country or territory
- United States
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction